We compared the effects of intravenous infusions of clonidine and placebo on heart rate variability in 10 healthy male controls. Clonidine produced a significant decrease in blood pressure and significantly decreased the heart rate variability during quiet standing. exerts its effect by stimulating alpha adrenoceptors in the brain stem.1) Recent evidence suggests that clonidine decreases heart rate (HR) variability both in experimental animals and in patients with hypertension.2),3) Clonidine produced a significant decrease of both mid frequency (MF) and high frequency (HF) power in subjects with essential hypertension in sitting posture.3) These studies used spectral analysis of HR and blood pressure (BP). Several reports suggest that vagal activity influences HR variability at all frequencies up to 0.5Hz, while the sympathetic nervous system affects HR variability below 0.15Hz.4)-6) Thus, the high frequency (HF: 0.2-0.5Hz) power is specifically related to vagal activity and the mid frequency (MF: 0.07-0.15Hz) power is dually influenced by cholinergic and beta-adrenergic activity. The relative influence of the two limbs of the autonomic nervous system on HR variability is shifted from vagal to sympathetic predominance during the change from supine to standing posture. We have been conducting studies on HR variability in normal controls and patients with, anxiety and depression. Our previous studies found that panic disorder patients have a decreased HR variability as measured by the standard deviation (SD), mean consecutive difference (MCD) and the SD
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We have been conducting studies on HR variability in normal controls and patients with, anxiety and depression. Our previous studies found that panic disorder patients have a decreased HR variability as measured by the standard deviation (SD), mean consecutive difference (MCD) and the SD R-R intervals reported in this study were measured in millimeters from the ECG strips manually.
The following variables were used in the analyses. R-R variability was calculated for 150 consecutive beats during the standing posture after 10min of quiet standing.
This method has been used previously.7),11),12) R-R variability was also calculated for the R-R intervals during 1min of resting supine posture and 1min of deep breathing.
The following measures of variability were used.7),11),12) Standard deviation (SD) of the R-R intervals, which measures the long-term variance, the mean consecutive difference of successive R-R intervals (MCD) and the standard deviation of the MCD (MCDSD), which measure the short-term variance of the R-R intervals.
The SD, MCD and MCDSD were all corrected for heart rate by dividing each of these measures by the mean R-R interval and multiplying it by 1,000.7),12) This was done because heart rate can influence the variance. These new measures are referred to in this paper as SDC, MCDC and MCDSDC.
Supine HR is the average of five heart rate values before standing up and standing HR is the average of values at 1 and 2min after standing up. Supine SBP and DBP are the averages of two values before standing up and standing SBP and DBP are the values 2min after standing up.
Statistical analysis BMDP statistical software (Berkeley, California, USA) was used for the analyses. Paired 't' tests were used to compare different variables between placebo and clonidine conditions. Two-tailed tests with a probability value of <0.05 were accepted as significant.
RESULTS
Heart rate and blood pressure Table I shows the values of HR and BP during placebo and clonidine conditions. Although there was no significant change in supine HR between placebo and clonidine conditions, standing HR was significantly higher for the clonidine condition.
The supine and standing SBPs and DBPs were significantly lower during clonidine condition.
R-R variability
There was no significant difference in any of the measures (SDC, MCDC Jpn. Heart J. M ay 1992 or MCDSDC) of R-R variability between the two conditions during supine or supine deep breathing conditions (Table I) . After quiet standing for 10min, the R-R variability was significantly lower during clonidine condition compared to the placebo condition as measured by MCDC and MCDSDC. Though the SDC was lower after clonidine administration, this was not significantly different from the placebo condition.
DISCUSSION
This pilot study examined the effects of clonidine on HR variability. Since we did not have access to computerized techniques to record and analyze the data, the interpretation of our findings is very limited. The signifi cant increase in HR upon standing after clonidine infusions is probably due to a reflex tachycardia due to a decrease in peripheral vascular resistance. There was a significant decrease of the standing HR variability measures, MCDC and MCDSDC.
It should be noted that the HR variability measures were corrected for the mean HR. Previous studies suggest that the MCD is a more statistically effective measure of short-term HR variability.7),11),12) There is also evidence suggesting that there is a high degree of correlation between the MCD and the 0.25Hz respiratory peak of the R-R 
